论文部分内容阅读
目的观察对比几种西药治疗小儿支气管炎患者的临床效果及安全性。方法将180例支气管炎患儿随机分为A组、B组、C组及D组各45例。A组给予愈美颗粒口服。B组给予孟鲁斯特钠联合酮替芬口服。C组给予乳糖酸阿奇霉素静脉滴注。D组给予盐酸氨溴索口服液联合复方异丙托溴铵,治疗后观察2组临床疗效及不良反应发生情况。结果 D组患者的总有效率明显高于其他3组,不良反应发生率低于其他3组,差异均有统计学意义(P<0.05)。结论临床采用盐酸氨溴索口服液联合复方异丙托溴铵治疗小儿支气管炎疗效显著,安全性高。
Objective To compare the clinical efficacy and safety of several western medicine in treating children with bronchitis. Methods 180 children with bronchitis were randomly divided into A group, B group, C group and D group 45 cases. Group A was given orally. Group B was given montelukast sodium and ketotifen orally. Group C was given azithromycin lactobionate intravenously. Group D was given ambroxol hydrochloride oral solution combined with ipratropium bromide. After treatment, the clinical efficacy and adverse reactions of the two groups were observed. Results The total effective rate of patients in group D was significantly higher than that of the other three groups, and the incidence of adverse reactions was lower than the other three groups (P <0.05). Conclusion Ambroxol hydrochloride oral solution combined with ipratropium bromide treatment of children with bronchitis significant effect, high safety.